111 related articles for article (PubMed ID: 19051733)
1. [Continuous intravenous prostacyclin therapy].
Miyaji K; Matsubara H
Nihon Rinsho; 2008 Nov; 66(11):2139-44. PubMed ID: 19051733
[TBL] [Abstract][Full Text] [Related]
2. Bosentan: new preparation. Pulmonary hypertension: an option before epoprostenol infusion.
Prescrire Int; 2005 Apr; 14(76):47-50. PubMed ID: 15875338
[TBL] [Abstract][Full Text] [Related]
3. [Current status and future prospect of prostacyclin therapy for pulmonary hypertension--intravenous, subcutaneous, inhaled and oral PGI2 derivatives].
Saji T; Nakayama T; Ishikita T; Matsuura H
Nihon Rinsho; 2001 Jun; 59(6):1132-8. PubMed ID: 11411125
[TBL] [Abstract][Full Text] [Related]
4. Advances in prostanoid infusion therapy for pulmonary arterial hypertension.
Doran A; Harris S; Goetz B
J Infus Nurs; 2008; 31(6):336-45. PubMed ID: 19018187
[TBL] [Abstract][Full Text] [Related]
5. Bloodstream infections among patients treated with intravenous epoprostenol or intravenous treprostinil for pulmonary arterial hypertension--seven sites, United States, 2003-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Mar; 56(8):170-2. PubMed ID: 17332729
[TBL] [Abstract][Full Text] [Related]
6. Treprostinil for pulmonary hypertension.
Vachiéry JL; Naeije R
Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):183-91. PubMed ID: 15151467
[TBL] [Abstract][Full Text] [Related]
7. Successful use of continuous intravenous prostacyclin in a patient with severe portopulmonary hypertension.
Kähler CM; Graziadei I; Wiedermann CJ; Kneussl MP; Vogel W
Wien Klin Wochenschr; 2000 Jul; 112(14):637-40. PubMed ID: 11008327
[TBL] [Abstract][Full Text] [Related]
8. Effects of tolazoline and prostacyclin on pulmonary hypertension in infants after cardiac surgery.
Schranz D; Zepp F; Iversen S; Wippermann C; Huth R; Zimmer B; Jüngst BK; Oelert H
Crit Care Med; 1992 Sep; 20(9):1243-9. PubMed ID: 1521438
[TBL] [Abstract][Full Text] [Related]
9. [Prostacyclin derivatives].
Nagaya N
Nihon Rinsho; 2008 Nov; 66(11):2145-50. PubMed ID: 19051734
[TBL] [Abstract][Full Text] [Related]
10. Subcutaneous implantation of a new intravenous pump system for prostacyclin treatment in patients with pulmonary arterial hypertension.
Desole S; Velik-Salchner C; Fraedrich G; Ewert R; Kähler CM
Heart Lung; 2012; 41(6):599-605. PubMed ID: 22920608
[TBL] [Abstract][Full Text] [Related]
11. Continuous therapy with intravenous prostacyclin for primary pulmonary hypertension: a bridge to heart-lung transplantation.
Kramer MR; Fucks S; Simon Z; Berkman N
Isr J Med Sci; 1993 Oct; 29(10):613-6. PubMed ID: 8244657
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic evaluation of continuous intravenous epoprostenol.
Chaumais MC; Jobard M; Huertas A; Vignand-Courtin C; Humbert M; Sitbon O; Rieutord A; Montani D
Expert Opin Drug Metab Toxicol; 2010 Dec; 6(12):1587-98. PubMed ID: 21077785
[TBL] [Abstract][Full Text] [Related]
13. [Transition from intravenous to subcutaneous prostacyclin in pulmonary hypertension].
Escribano Subías P; Cea-Calvo L; Tello de Menesses R; Gómez Sánchez MA; Delgado Jiménez JF; Sáenz de la Calzada C
Rev Esp Cardiol; 2003 Aug; 56(8):818-21. PubMed ID: 12892628
[TBL] [Abstract][Full Text] [Related]
14. Rapid switch from intravenous epoprostenol to intravenous treprostinil in patients with pulmonary arterial hypertension.
Sitbon O; Manes A; Jais X; Pallazini M; Humbert M; Presotto L; Paillette Ld; Zaccardelli D; Davis G; Jeffs R; Simonneau G; Galie N
J Cardiovasc Pharmacol; 2007 Jan; 49(1):1-5. PubMed ID: 17261956
[TBL] [Abstract][Full Text] [Related]
15. [Feasibility of cardiopulmonary rehabilitation in patients with idiopathic pulmonary arterial hypertension treated with intravenous prostacyclin infusion therapy].
Uchi M; Saji T; Harada T
J Cardiol; 2005 Nov; 46(5):183-93. PubMed ID: 16320975
[TBL] [Abstract][Full Text] [Related]
16. Treprostinil: new drug. Pulmonary artery hypertension: just another (disappointing) prostacycline analogue.
Prescrire Int; 2006 Oct; 15(85):177-9. PubMed ID: 17128524
[TBL] [Abstract][Full Text] [Related]
17. The influence of continuous intravenous prostacyclin therapy for primary pulmonary hypertension on the timing and outcome of transplantation.
Conte JV; Gaine SP; Orens JB; Harris T; Rubin LJ
J Heart Lung Transplant; 1998 Jul; 17(7):679-85. PubMed ID: 9703232
[TBL] [Abstract][Full Text] [Related]
18. Reversal of pulmonary hypertension and subsequent repair of atrial septal defect after treatment with continuous intravenous epoprostenol.
Frost AE; Quiñones MA; Zoghbi WA; Noon GP
J Heart Lung Transplant; 2005 Apr; 24(4):501-3. PubMed ID: 15797757
[TBL] [Abstract][Full Text] [Related]
19. Endothelin-1 across the lung circulation in patients with pulmonary arterial hypertension and influence of epoprostenol infusion.
Selimovic N; Andersson B; Bergh CH; Sakiniene E; Carlsten H; Rundqvist B
J Heart Lung Transplant; 2009 Aug; 28(8):808-14. PubMed ID: 19632577
[TBL] [Abstract][Full Text] [Related]
20. Inhaled epoprostenol for the treatment of pulmonary arterial hypertension in critically ill adults.
Buckley MS; Feldman JP
Pharmacotherapy; 2010 Jul; 30(7):728-40. PubMed ID: 20575636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
